Annual EBITDA
Summary
- Current Value
- As of today, STE annual EBITDA is $1.46B, down -0.70% on
- Historical Performance
- STE annual EBITDA is up +24.48% over the past 3 years, and up +94.58% over the past 5 years
- All-Time High Comparison
- STE annual EBITDA is currently -0.70% below its historical high of $1.47B set on
- 3-Year Low Comparison
- STE annual EBITDA is +24.48% above its 3-year low of $1.18B reached on an earlier date
- Sector Comparison
- STE annual EBITDA is higher than 94.82% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.46B | -0.7% | +24.5% | +94.6% | +455.3% | |
| Quarterly EBITDA | $390.60M | +14.7% | +21.7% | +94.7% | +490.6% | |
| TTM EBITDA | $1.55B | +7.0% | +17.8% | +98.1% | +864.6% | |
| Price | $268.65 | +27.8% | +33.0% | +45.7% | +643.1% | |
| PE Ratio | 38.24 | -14.2% | – | +4.7% | -27.0% | |
| Annual Revenue | $5.46B | +6.2% | +19.1% | +80.1% | +334.1% | |
| Annual EPS | $6.35 | +66.7% | +155.8% | +33.3% | +193.8% | |
| Annual EBIT | $986.51M | +8.7% | +58.6% | +77.9% | +376.1% | |
| Annual Net Income | $611.56M | +10.5% | +151.8% | +49.9% | +376.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.47B | -0.7% | |
| 5Y | $1.47B | -0.7% | |
| All | $1.47B | -0.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.18B | N/A | +24.5% |
| 5Y | $751.73M | N/A | +94.6% |
| All | $212.10K | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of STE?
As of today, STE annual EBITDA is $1.46B
What is 1-year change in STE annual EBITDA?
STE annual EBITDA is down -0.70% year-over-year
What is 3-year change in STE annual EBITDA?
STE annual EBITDA is up +24.48% over the past 3 years
How far is STE annual EBITDA from its all-time high?
STE annual EBITDA is currently -0.70% below its historical high of $1.47B set on March 31, 2024
How does STE annual EBITDA rank versus sector peers?
STE annual EBITDA is higher than 94.82% of companies in Healthcare sector
When is STE next annual earnings release?
As of today, the next annual earnings release for STE has not been scheduled
Quarterly EBITDA
Summary
- Current Value
- As of today, STE quarterly EBITDA is $390.60M, up +6.63% on
- Historical Performance
- STE quarterly EBITDA is up +14.70% year-over-year, and up +21.69% over the past 3 years
- All-Time High Comparison
- STE quarterly EBITDA is currently -6.20% below its historical high of $416.44M set on
- 3-Year Low Comparison
- STE quarterly EBITDA is +18.04% above its 3-year low of $330.91M reached on an earlier date
- Sector Comparison
- STE quarterly EBITDA is higher than 94.39% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $390.60M | +6.6% | +14.7% | +21.7% | +94.7% | |
| Annual EBITDA | $1.46B | – | -0.7% | +24.5% | +94.6% | |
| TTM EBITDA | $1.55B | +3.3% | +7.0% | +17.8% | +98.1% | |
| Price | $268.65 | +11.8% | +27.8% | +33.0% | +45.7% | |
| PE Ratio | 38.24 | +11.8% | -14.2% | – | +4.7% | |
| Quarterly Revenue | $1.46B | +5.0% | +9.9% | +21.6% | +93.1% | |
| Quarterly EPS | $1.94 | +8.2% | +28.4% | +161.6% | +57.5% | |
| Quarterly EBIT | $268.00M | +7.8% | +19.0% | +43.2% | +83.3% | |
| Quarterly Net Income | $192.50M | +8.2% | +27.2% | +161.1% | +81.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $416.44M | -6.2% | |
| 3Y | $416.44M | -6.2% | |
| 5Y | $416.44M | -6.2% | |
| All | $416.44M | -6.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $366.30M | +6.6% | |
| 3Y | $330.91M | N/A | +18.0% |
| 5Y | $219.90M | +77.6% | |
| All | -$49.62M | +887.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of STE?
As of today, STE quarterly EBITDA is $390.60M
What is STE quarterly EBITDA most recent change?
STE quarterly EBITDA was up +6.63% on September 30, 2025
What is 1-year change in STE quarterly EBITDA?
STE quarterly EBITDA is up +14.70% year-over-year
How far is STE quarterly EBITDA from its all-time high?
STE quarterly EBITDA is currently -6.20% below its historical high of $416.44M set on March 31, 2025
How does STE quarterly EBITDA rank versus sector peers?
STE quarterly EBITDA is higher than 94.39% of companies in Healthcare sector
When is STE next earnings release?
The next earnings release for STE is on
TTM EBITDA
Summary
- Current Value
- As of today, STE TTM EBITDA is $1.55B, up +3.34% on
- Historical Performance
- STE TTM EBITDA is up +7.05% year-over-year, and up +17.75% over the past 3 years
- All-Time High Comparison
- STE TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- STE TTM EBITDA is +17.50% above its 3-year low of $1.32B reached on an earlier date
- Sector Comparison
- STE TTM EBITDA is higher than 94.67% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.55B | +3.3% | +7.0% | +17.8% | +98.1% | |
| Annual EBITDA | $1.46B | – | -0.7% | +24.5% | +94.6% | |
| Quarterly EBITDA | $390.60M | +6.6% | +14.7% | +21.7% | +94.7% | |
| Price | $268.65 | +11.8% | +27.8% | +33.0% | +45.7% | |
| PE Ratio | 38.24 | +11.8% | -14.2% | – | +4.7% | |
| TTM Revenue | $5.70B | +2.4% | +7.1% | +19.4% | +88.7% | |
| TTM EPS | $7.03 | +6.5% | +60.5% | +6715.3% | +42.1% | |
| TTM EBIT | $1.06B | +4.2% | +12.3% | +53.4% | +83.4% | |
| TTM Net Income | $690.72M | +6.3% | +16.4% | +7504.0% | +63.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.55B | at high | |
| 3Y | $1.55B | at high | |
| 5Y | $1.55B | at high | |
| All | $1.55B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.45B | N/A | +6.8% |
| 3Y | $1.32B | N/A | +17.5% |
| 5Y | $809.10M | N/A | +91.5% |
| All | -$6.70M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of STE?
As of today, STE TTM EBITDA is $1.55B
What is STE TTM EBITDA most recent change?
STE TTM EBITDA was up +3.34% on September 30, 2025
What is 1-year change in STE TTM EBITDA?
STE TTM EBITDA is up +7.05% year-over-year
How far is STE TTM EBITDA from its all-time high?
STE TTM EBITDA is currently at its all-time high
How does STE TTM EBITDA rank versus sector peers?
STE TTM EBITDA is higher than 94.67% of companies in Healthcare sector
When is STE next earnings release?
The next earnings release for STE is on
EBITDA Formula
Data Sources & References
- STE Official Website www.steris.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1757898/000162828025050160/0001628280-25-050160-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1757898/000175789825000005/0001757898-25-000005-index.htm
- STE Profile on Yahoo Finance finance.yahoo.com/quote/STE
- STE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ste
